nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Capitalizing on Prescribing Pattern Variation to Compare Medications for Type 2 Diabetes
|
Prentice, Julia C. |
|
2014 |
17 |
8 |
p. 854-862 9 p. |
artikel |
2 |
Conceptual Model and Economic Experiments to Explain Nonpersistence and Enable Mechanism Designs Fostering Behavioral Change
|
Djawadi, Behnud Mir |
|
2014 |
17 |
8 |
p. 814-822 9 p. |
artikel |
3 |
Copyright/Subscription
|
|
|
2014 |
17 |
8 |
p. iii- 1 p. |
artikel |
4 |
Cost-Effectiveness of Telaprevir in Patients with Genotype 1 Hepatitis C in Australia
|
Warren, Emma |
|
2014 |
17 |
8 |
p. 792-800 9 p. |
artikel |
5 |
Cost-Effectiveness of Three Adjunct Cellular/Tissue-Derived Products Used in the Management of Chronic Venous Leg Ulcers
|
Carter, Marissa J. |
|
2014 |
17 |
8 |
p. 801-813 13 p. |
artikel |
6 |
Does Convenience Matter in Health Care Delivery? A Systematic Review of Convenience-Based Aspects of Process Utility
|
Higgins, A. |
|
2014 |
17 |
8 |
p. 877-887 11 p. |
artikel |
7 |
Economic Evaluation of a Cluster Randomized Trial of Interventions to Improve Health Workers’ Practice in Diagnosing and Treating Uncomplicated Malaria in Cameroon
|
Mangham-Jefferies, Lindsay |
|
2014 |
17 |
8 |
p. 783-791 9 p. |
artikel |
8 |
Editorial Board
|
|
|
2014 |
17 |
8 |
p. IFC- 1 p. |
artikel |
9 |
ERRATUM
|
|
|
2014 |
17 |
8 |
p. 896- 1 p. |
artikel |
10 |
Evolution of Drug Reimbursement in Canada: The Pan-Canadian Pharmaceutical Alliance for New Drugs
|
Husereau, Don |
|
2014 |
17 |
8 |
p. 888-894 7 p. |
artikel |
11 |
Instructions for Authors
|
|
|
2014 |
17 |
8 |
p. I-II nvt p. |
artikel |
12 |
Mapping from the Health Assessment Questionnaire to the EQ-5D: The Impact of Different Algorithms on Cost-Effectiveness Results
|
Pennington, Becky |
|
2014 |
17 |
8 |
p. 762-771 10 p. |
artikel |
13 |
Optimizing the Position and Use of Omalizumab for Severe Persistent Allergic Asthma Using Cost-Effectiveness Analysis
|
Faria, Rita |
|
2014 |
17 |
8 |
p. 772-782 11 p. |
artikel |
14 |
Parents’ Willingness to Pay for Biologic Treatments in Juvenile Idiopathic Arthritis
|
Burnett, Heather F. |
|
2014 |
17 |
8 |
p. 830-837 8 p. |
artikel |
15 |
Performance of the UKPDS Outcomes Model for Prediction of Myocardial Infarction and Stroke in the ADDITION-Europe Trial Cohort: Does the ADDITION Validation Add Up?
|
Gray, Alastair |
|
2014 |
17 |
8 |
p. 895-896 2 p. |
artikel |
16 |
Predicting Adherence to Medications Using Health Psychology Theories: A Systematic Review of 20 Years of Empirical Research
|
Holmes, Emily A.F. |
|
2014 |
17 |
8 |
p. 863-876 14 p. |
artikel |
17 |
Table of Contents
|
|
|
2014 |
17 |
8 |
p. i-ii nvt p. |
artikel |
18 |
Toward a Functional Definition of a “Rare Disease” for Regulatory Authorities and Funding Agencies
|
Clarke, Joe T.R. |
|
2014 |
17 |
8 |
p. 757-761 5 p. |
artikel |
19 |
US Valuation of Health Outcomes Measured Using the PROMIS-29
|
Craig, Benjamin M. |
|
2014 |
17 |
8 |
p. 846-853 8 p. |
artikel |
20 |
Validation of the Patient Perception of Intensity of Urgency Scale in Patients with Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia
|
Mathias, Susan D. |
|
2014 |
17 |
8 |
p. 823-829 7 p. |
artikel |
21 |
Valuations of Genetic Test Information for Treatable Conditions: The Case of Colorectal Cancer Screening
|
Kilambi, Vikram |
|
2014 |
17 |
8 |
p. 838-845 8 p. |
artikel |